Stevens-Johnson syndrome with intrahepatic cholestasis induced by clindamycin or chlorpheniramine;Síndrome de Stevens Johnson más colestasis intrahepática inducido por clindamicina o clorfeniramina

Dermatology Online Journal

Volumn 15, Issue 5, 2009, Pages

  Sahagun Flores J E ^a,b   Soto Ortiz, J A ^a   Tovar Mendez C E ^a   Cardenas Ochoa E C ^a   Hernandez Flores G ^c  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETAMETHASONE; CHLORPHENIRAMINE; CLINDAMYCIN; ERYTHROMYCIN; IBUPROFEN; MEFENAMIC ACID; PARACETAMOL; SULINDAC; VANCOMYCIN; ENALAPRIL; INSULIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; BRONCHITIS; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEADACHE; HEPATITIS; HUMAN; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LABORATORY TEST; PRURITUS; SEROLOGY; STEVENS JOHNSON SYNDROME; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HAND DISEASE; MIDDLE AGED; MUCOSA INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; SKIN DISEASE;

ACETAMINOPHEN; BETAMETHASONE; BRONCHITIS; CHLORPHENIRAMINE; CHOLESTASIS, INTRAHEPATIC; CLINDAMYCIN; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; INSULIN; METHYLPREDNISOLONE; MIDDLE AGED; MUCOSITIS; STEVENS-JOHNSON SYNDROME;

EID: 67249144103     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Morelli MS, O'Brien FX. Stevens-Johnson Syndrome and cholestatic hepatitis. Dig Dis Sci. 2001 Nov;46(11):2385-2388 Review. [PubMed]
2. Alexander II, Greenberger PA. Vancomycin-induced Stevens- Johnson syndrome. Allergy Asthma Proc. 1996 Mar-Apr;17(2):75-78 [PubMed]
3. McArthur JE, Dyment PG. Stevens-Johnson syndrome with hepatitis following therapy with ampicillin and cephalexin. N Z Med J. 1975 Apr 23;81(538):390-392 [PubMed]
4. Limauro DL, Chan-Tompkins NH, Carter RW, Brodmerkel GJ Jr, Agrawal RM. Amoxicillin/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome. Ann Pharmacother. 1999 May;33(5):560-564 [PubMed]
5. Brkljacic N, Gracin S, Prkacin I, Sabljar-Matovinovic M, Mrzljak A, . Nemet Z. Stevens-Johnson syndrome as an unusual adverse effect of azithromycin. Acta Dermatovenerol Croat. 2006;14(1):40-45 [PubMed]
6. Schonheyder H. Stevens-Johnson syndrome associated with intrahepatic cholestasis and respiratory disease: a case report. Acta Derm Venereol. 1981;61(2):171-173 [PubMed] (Pubitemid 11147573)
7. Chan JC, Lai FM, Critchley JA. A case of Stevens-Johnson syndrome, cholestatic hepatitis and haemolytic anaemia associated with use of mefenamic acid. Drug Saf. 1991 May-Jun;6(3):230-234 [PubMed]
8. Klein SM, Khan MA. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy. J Rheumatol. 1983 Jun;10(3):512-513 [PubMed]
9. Nakajima T, Yamanoshita O, Kamijima M, Kishi R, Ichihara G. Generalized skin reactions in relation to trichloroethylene exposure: a review from the viewpoint of drug-metabolizing enzymes. J Occup Health. 2003 Jan;45(1):8-14. Review. [PubMed] (Pubitemid 36237121)
10. Hisanaga N, Jonai H, Yu X, Ogawa Y, Mori I, Kamijima M, Ichihara G, Shibata E, Takeuchi Y. [Stevens-Johnson syndrome accompanied by acute hepatitis in workers exposed to trichloroethylene or tetrachloroethylene] Sangyo Eiseigaku Zasshi. 2002 Mar;44(2):33-49. Review. Japanese. [PubMed]
11. Forman R, Koren G, Shear NH.Erythema multiforme, Stevens- Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf. 2002;25(13):965-972 [PubMed]
12. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC; SCAR Study Group. Severe Cutaneous Adverse Reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002 Aug;138(8):1019-1024 [PubMed]
13. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet. 1999 Jun 26;353 (9171):2190-2194 [PubMed]
14. Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ. Ocular manifestations and complications of Stevens- Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy. 2007 May;62(5):527-531 Epub 2007 Feb 20. [PubMed]
15. Wong KC, Kennedy PJ, Lee S. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol. 1999 Aug;40(3):131-134 [PubMed] (Pubitemid 29374360)
16. Khalili B, Bahna SL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol. 2006 Sep;97(3):272-80; quiz 281-3, 320. [PubMed]
17. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002 Jun;8(1):5. Review. [PubMed]
18. Mohi-ud-din R, Lewis JH. Drug- and chemical-induced cholestasis. Clin Liver Dis. 2004 Feb;8(1):95-132, vii. Review. [PubMed]
19. Wolf R, Matz H, Marcos B, Orion E. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Clin Dermatol. 2005 May-Jun;23 (3):311-314
20. Ghislain PD, Roujeau JC.Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002 Jun;8(1):5. Review.
21. Samimi SS, Siegfried E. Pediatr Dermatol. 2002 Jan-Feb;19 (1):82-84
22. Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy. Pediatr Dermatol. 2002 Jan-Feb;19(1):52-55 [PubMed]
23. Routledge PA, Lindquist M, Edwards IR. Spontaneous reporting of suspected adverse reactions to antihistamines: a national and international perspective. Clin Exp Allergy. 1999 Jul;29 Suppl 3:240-6; discussion 247-250 [PubMed]
24. Lammintausta K, Tokola R, Kalimo K. Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure. Br J Dermatol. 2002 Apr;146(4):643-648 [PubMed] (Pubitemid 34437778)
25. João EC, Calvet GA, Menezes JA, D'Ippolito MM, Cruz ML, Salgado LA, Matos HJ. Nevirapine toxicity in a cohort of HIV-1- infected pregnant women. Am J Obstet Gynecol. 2006 Jan;194 (1):199-202. [PubMed] (Pubitemid 43017797)